Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication

By sjmartinez • January 8, 2025

Blair CS, Shoptaw SJ. Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication. Top Antivir Med. 2024 Dec 23;32(5):571-578. PMID: 39765236.

Tags: Infectious Diseases, Publications

Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083

Moore HP, Fogel JM, Marzinke MA, Halvas EK, Parikh UM, Mellors JW, Penrose KJ, Seisa M, Petropoulos C, Price AL, Moser A, Wang Z, McCauley[...]

Development of a feasible and portable electronic flag for near-real-time identification of renal replacement therapy in the Veterans Health Administration

Golenbock SW, Basnet D, Mull HJ, Lamkin R, Harvey K, Shin M, Strymish JM, Leatherman S, Ferguson R, Branch-Elliman W. Development of a feasible and[...]

Patient-reported quality of life and perceived disease burden in mexican patients with neuromyelitis optica spectrum disorder: a cross-sectional analysis

García-Sarreón A, Martinez-Lopez Y, Gómez-Figueroa E, Rivas-Alonso V, Flores J, Behne JM, Yeaman MR, Smith TJ, Behne MK, Delgado-Garcia G, Corona T. Patient-reported quality of[...]